Hjem › Brystkreft › Florida › Miami
Kliniske studier for Brystkreft i Miami, FL
42 studier for Brystkreft søker deltakere på steder i og rundt Miami (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
RekruttererFase 3
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Miami
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Miami Cancer Institute, Miami
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruttererFase 2
- Sylvester Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekruttererFase 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekrutterer
- Werheim Cancer Institute, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Miami, Miami
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RekruttererFrivillige helsepersonell ønskes velkommen
- TopLine MD Alliance, Miami
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
RekruttererFase 2
- Baptist Alliance Miami Cancer Institute, Miami
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Miami (Data Collection Only), Miami
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Miami Cancer Institute at Baptist Health Inc., Miami
- University of Miami, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- University of Miami, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- University of Miami, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RekruttererFase 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruttererFase 1/2
- Sylvester Comprehensive Cancer Center, Miami
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- University Of Miami-SCCC-Miami, Miami
- University of Miami_SCCC - Kendall, Miami
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruttererFase 2
- Miami Cancer Institute/Baptist Hospital of Miami, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RekruttererFase 2
- Baptist Health Herbert Wertheim Cancer Institute, Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RekruttererFase 2
- Miami Baptist Cancer Institute/, Miami
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
SABER Study for Selected Early Stage Breast Cancer
Rekrutterer
- University of Miami, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- University of Miami Hospital and Clinics, Miami
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekruttererFase 3
- Miami Cancer Institute, Miami
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
RekruttererFase 3
- Baptist Health South Florida, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Miami, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruttererFase 2
- Miami Cancer Institute at Baptist Health (Kendall), Miami
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
RekruttererFase 1/2
- Miami Cancer Institute at Baptist Health, Miami
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
Rekrutterer
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RekruttererFase 2
- Baptist Alliance - McI, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Rekrutterer
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Miami Cancer Institute, Miami
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Rekrutterer
- Miami Cancer Institute at Baptist Health, Inc., Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Miami
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- Sylvester Comprehensive Cancer Center - University of Miami, Miami
- Miami Cancer Institute at Baptist Health, Inc, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekruttererFase 2
- AP Medical Research, Miami
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Miami
- Kreft (alle typer)36 studier
- Ikke-småcellet lungekreft31 studier
- Prostatakreft27 studier
- Fedme27 studier
- Akut myelogen leukemi24 studier
- Metastatisk kreft23 studier
- Overvekt23 studier
- Eggstokkreft23 studier
- Ulcerøs kolitt21 studier
- Multipelt myelom21 studier
- Alzheimers sykdom20 studier
- Lungekreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.